{
    "clinical_study": {
        "@rank": "82503", 
        "brief_summary": {
            "textblock": "The purpose of this study is to improve understanding of neurological conditions. Patients\n      participating in this study will continue receiving medical care, routine laboratory tests,\n      and diagnostics tests (X-rays, CT-scans, and nuclear imaging), from their primary care\n      physician.  Doctors at the NIH plan to follow these patients and offer advice and assistance\n      to their primary care physicians."
        }, 
        "brief_title": "Diagnosis and Natural History Study of Patients With Neurological Conditions", 
        "completion_date": "January 2006", 
        "condition": [
            "Alzheimer's Disease", 
            "Dementia", 
            "Movement Disorder", 
            "Multiple System Atrophy", 
            "Parkinson's Disease"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Alzheimer Disease", 
                "Dementia", 
                "Movement Disorders", 
                "Parkinson Disease", 
                "Multiple System Atrophy", 
                "Shy-Drager Syndrome", 
                "Atrophy"
            ]
        }, 
        "detailed_description": {
            "textblock": "The objective of this protocol is to provide diagnosis and follow Experimental Therapeutics\n      Branch (ETB) patients not currently entered on another research protocol.  No\n      investigational treatments will be administered on this protocol, and the NIH physicians\n      will be playing largely a consultative role to the patient's primary physician."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "INCLUSION CRITERIA:\n\n        Patients may be included on this protocol if they have an identifiable neurological\n        disorder or represent a diagnostic puzzle.  These disorders would include patients with\n        Parkinson's disease, Alzheimer's disease, multiple system atrophy, progressive\n        supranuclear palsy, restless legs syndrome, other cognitive and movement disorders, and\n        diagnostic puzzles.\n\n        Patients 18-90 years of age, inclusive, are eligible."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "enrollment": "600", 
        "firstreceived_date": "November 3, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00001549", 
            "org_study_id": "960009", 
            "secondary_id": "96-N-0009"
        }, 
        "keyword": [
            "Movement Disorders", 
            "Parkinson's", 
            "Alzheimer's", 
            "Screening", 
            "Diagnostic Puzzles", 
            "Alzheimer Disease", 
            "Progressive Supranuclear Palsy", 
            "PSP", 
            "Restless Leg Syndrome", 
            "RLS", 
            "Parkinsonism", 
            "PD"
        ], 
        "lastchanged_date": "March 3, 2008", 
        "location": {
            "facility": {
                "address": {
                    "city": "Bethesda", 
                    "country": "United States", 
                    "state": "Maryland", 
                    "zip": "20892"
                }, 
                "name": "National Institute of Neurological Disorders and Stroke (NINDS)"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "Diagnosis and Natural History Protocol for Patients With Neurological Conditions", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "N/A", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00001549"
        }, 
        "source": "National Institutes of Health Clinical Center (CC)", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "National Institute of Neurological Disorders and Stroke (NINDS)", 
                "agency_class": "NIH"
            }
        }, 
        "start_date": "October 1995", 
        "study_design": "N/A", 
        "study_type": "Observational", 
        "verification_date": "January 2006"
    }, 
    "geocoordinates": {
        "National Institute of Neurological Disorders and Stroke (NINDS)": "38.985 -77.095"
    }
}